It has been demonstrated that treatment of ovarian cancer cells induced HSP27, HSP70 and HSP90 as well as HSP60 and TNF receptor-associated protein 1 (TRAP-1) and the use of HSP inhibitors was shown to be active against the growth of resistant tumors. This evidence concerns the gene TRAP1 and ovarian cancer.